103 participants
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-18
- Start Date:
- 2024-03-11
- Completion:
- 2026-08-31
Conditions
- Breast Cancer
- Small Cell Lung Cancer
- Ovarian Cancer
- Gastric Cancer
- Hormone-receptor-positive Breast Cancer
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Advanced Solid Tumor
- Endometrial Cancer
- Prostate Cancer
- TNBC - Triple-Negative Breast Cancer
- GastroEsophageal Cancer
- Bladder Cancer
Interventions
- DRUG
No Results Yet